European Registry on Thoracic Aortic Arch Repair Using Castor and Cratos Branched Stent Grafts

What this Trial Is About

This research evaluates the safety and performance of the Castor and Cratos Branched Aortic Stent Graft Systems for treating thoracic aortic diseases in the descending aorta. The study collects data from around 100 patients in European hospitals to understand how these devices perform in everyday medical practice over short, medium, and long terms. Participants receive treatment with either the Castor or Cratos stent grafts designed to support the aortic arch and left subclavian artery. The study includes both retrospective and prospective data collection, following patients according to each hospitals standard care practices after device implantation. Throughout the study, researchers monitor participants health using measures such as 30-day mortality, technical success within 24 hours, clinical success up to 5 years, rates of complications like endoleaks, branch occlusion, strokes, and reinterventions. Follow-up assessments occur at 30 days, 6 months, and annually up to 5 years, with the entire study lasting until 2033.

European Multi-Centre Post-Market Registry on Thoracic Endovascular Arch Repair Using Castor™ and Cratos™